Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy

por Ying, Honggang, Xu, Jian, Zhang, Xiaozhen, Liang, Tingbo, Bai, Xueli
Publicado 2022

Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix

por Duan, Yi, Zhang, Xiaozhen, Ying, Honggang, Xu, Jian, Yang, Hanshen, Sun, Kang, He, Lihong, Li, Muchun, Ji, Yongtao, Liang, Tingbo, Bai, Xueli
Publicado 2023

Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells

por Lao, Mengyi, Zhang, Xiaozhen, Ma, Tao, Xu, Jian, Yang, Hanshen, Duan, Yi, Ying, Honggang, Zhang, Xiaoyu, Guo, Chengxiang, Qiu, Junyu, Bai, Xueli, Liang, Tingbo
Publicado 2021

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

por Zhang, Xiaozhen, Lao, Mengyi, Xu, Jian, Duan, Yi, Yang, Hanshen, Li, Muchun, Ying, Honggang, He, Lihong, Sun, Kang, Guo, Chengxiang, Chen, Wen, Jiang, Haitao, Zhang, Xiaoyu, Bai, Xueli, Liang, Tingbo
Publicado 2022

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer

por Yang, Hanshen, Zhang, Xiaozhen, Lao, Mengyi, Sun, Kang, He, Lihong, Xu, Jian, Duan, Yi, Chen, Yan, Ying, Honggang, Li, Muchun, Guo, Chengxiang, Lu, Qingsong, Wang, Sicheng, Su, Wei, Liang, Tingbo, Bai, Xueli
Publicado 2022